JANINE BENEDETTO: Open Payments
NPI 1689206856 · GREENVILLE, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$600 in 31 payments from 12 companies in 2025. Trend: 2023 $123 · 2024 $422 · 2025 $600
Food & beverage: $600
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 9 | $148 |
| ABBVIE INC. | 4 | $75 |
| Gilead Sciences, Inc. | 2 | $67 |
| Daiichi Sankyo Inc. | 3 | $64 |
| Pharmacosmos Therapeutics Inc. | 4 | $60 |
| Eisai Inc. | 2 | $48 |
| TerSera Therapeutics LLC | 2 | $30 |
| PharmaEssentia USA Corporation | 1 | $25 |
| AstraZeneca Pharmaceuticals LP | 1 | $24 |
| Geron Corporation | 1 | $22 |
Products named: TECVAYLI, VENCLEXTA, Trodelvy, Enhertu, MONOFERRIC, Lenvima, BESREMI, TAGRISSO.
Industry payments across SC — which companies pay providers there.
